Cubist Pharmaceuticals, Inc. (CBST) Tops Q1 EPS by 1c

Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) reported Q1 EPS of $0.45, $0.01 better than the analyst estimate of $0.44. Revenue for the quarter came in at $211.7 million versus the consensus estimate of $210.54 million.

For earnings history and earnings-related data on Cubist Pharmaceuticals, Inc. (CBST) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Wolfe Research upgrades Biogen, AbbVie on pipeline strength and valuation
• Brinker Int'l (EAT) PT Raised to $285 at UBS Following 'Impressive' Q4 Outperformance